Related Experiment Video
Updated: Jul 30, 2025

Real-Time Electrocardiogram Monitoring During Treadmill Training in Mice
Published on: May 5, 2022
Arrhythmogenic Cardiomyopathy and Athletes: A Dangerous Relationship
Fernando de la Guía-Galipienso1, Koldo Ugedo-Alzaga2, Gonzalo Grazioli3
1The Glorieta Policlinic, Denia, Alicante, Spain; REMA-Sports Cardiology Clinic, Denia, Alicante, Spain; Cardiology Service, Hospital HCB Benidorm, Alicante, Spain; School of Medicine, Catholic University of Valencia San Vicente Mártir, Valencia, Spain.
Insights
Arrhythmogenic cardiomyopathy (ACM) affects the heart muscle, increasing risks for arrhythmias and sudden cardiac death (SCD), particularly in athletes. Exercise can worsen RV function in hereditary ACM cases.
Area of Science:
- Cardiology
- Genetics
- Sports Medicine
Background:
- Arrhythmogenic cardiomyopathy (ACM) involves fibro-adipose tissue replacing myocardium, leading to ventricular arrhythmias (VA) and sudden cardiac death (SCD).
- ACM affects 1:2000 to 1:5000 individuals, predominantly males, with onset typically in the 2nd to 4th decade.
- ACM is a significant cause of SCD in young individuals, especially athletes, with reported incidence in SCD victims ranging from 3% to 20%.
Purpose of the Study:
- To review the impact of exercise on the clinical course of hereditary arrhythmogenic cardiomyopathy.
- To discuss diagnostic tools, risk stratification methods, and therapeutic strategies for managing ACM.
- To highlight the challenges in estimating SCD incidence due to ACM in athletic populations.
Main Methods:
- Literature review focusing on arrhythmogenic cardiomyopathy, exercise, and sudden cardiac death.
- Analysis of studies investigating the relationship between physical activity and ACM progression.
- Synthesis of current knowledge on diagnostic and therapeutic approaches for ACM.
Main Results:
- Competitive sports and high-intensity training can exacerbate cardiac events in ACM patients.
- Exercise may worsen right ventricular (RV) function in hereditary ACM.
- Estimating SCD incidence in athletes with ACM presents significant challenges.
Conclusions:
- Exercise has complex implications for individuals with arrhythmogenic cardiomyopathy, potentially worsening outcomes.
- Comprehensive management strategies including risk stratification and tailored therapies are crucial for ACM patients.
- Further research is needed to clarify the precise role of exercise and improve management protocols for ACM, especially in athletes.
Abstract:
Arrhythmogenic cardiomyopathy (ACM) is a disease characterized by a progressive replacement of myocardium by fibro-adipose material, predisposing to ventricular arrhythmias (VA) and sudden cardiac death (SCD). Its prevalence is estimated at 1:2000 to 1:5000, with a higher incidence in males, and clinical onset is usually between the 2nd and 4th decade of life. The prevalence of ACM in SCD victims is relatively high, making it one of the most common etiologies in young patients with SCD, especially if they are athletes. Cardiac events occur more frequently in individuals with ACM who participate in competitive sports and/or high-intensity training. In effect, exercise activity can worsen RV function in cases of hereditary ACM. Estimating the incidence of SCD caused by ACM in athletes remains challenging, being reported frequency ranging from 3% to 20%. Here, we review the potential implications of exercising on the clinical course of the classical genetic form of ACM, as well as the diagnostic tools, risk stratification, and the different therapeutic tools available for managing ACM.
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Mechanism of Cardiac Arrhythmias
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

